These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18524586)

  • 1. Cubyl amides: novel P2X7 receptor antagonists.
    Gunosewoyo H; Guo JL; Bennett MR; Coster MJ; Kassiou M
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3720-3. PubMed ID: 18524586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small, non-peptide C5a receptor antagonists: part 2.
    Blagg J; Mowbray C; Pryde D; Salmon G; Fairman D; Schmid E; Beaumont K
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5605-8. PubMed ID: 18804369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Arylpyrimidines: novel CRF-1 receptor antagonists.
    Yoon T; De Lombaert S; Brodbeck R; Gulianello M; Krause JE; Hutchison A; Horvath RF; Ge P; Kehne J; Hoffman D; Chandrasekhar J; Doller D; Hodgetts KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4486-90. PubMed ID: 18672365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors.
    Furber M; Alcaraz L; Bent JE; Beyerbach A; Bowers K; Braddock M; Caffrey MV; Cladingboel D; Collington J; Donald DK; Fagura M; Ince F; Kinchin EC; Laurent C; Lawson M; Luker TJ; Mortimore MM; Pimm AD; Riley RJ; Roberts N; Robertson M; Theaker J; Thorne PV; Weaver R; Webborn P; Willis P
    J Med Chem; 2007 Nov; 50(24):5882-5. PubMed ID: 17963373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
    Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screening.
    Gunosewoyo H; Coster MJ; Bennett MR; Kassiou M
    Bioorg Med Chem; 2009 Jul; 17(14):4861-5. PubMed ID: 19540765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
    Jolidon S; Alberati D; Dowle A; Fischer H; Hainzl D; Narquizian R; Norcross R; Pinard E
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5533-6. PubMed ID: 18805008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers.
    Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1666-9. PubMed ID: 19233648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.
    McAtee JJ; Dodson JW; Dowdell SE; Erhard K; Girard GR; Goodman KB; Hilfiker MA; Jin J; Sehon CA; Sha D; Shi D; Wang F; Wang GZ; Wang N; Wang Y; Viet AQ; Yuan CC; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3716-9. PubMed ID: 18524591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.
    Kuduk SD; DiPardo RM; Chang RK; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3608-12. PubMed ID: 17482459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Jahangir A; Alam M; Carter DS; Dillon MP; Bois DJ; Ford AP; Gever JR; Lin C; Wagner PJ; Zhai Y; Zira J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1632-5. PubMed ID: 19231178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of piperidine carboxamide TRPV1 antagonists.
    Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain.
    Rappold PM; Lynd-Balta E; Joseph SA
    Brain Res; 2006 May; 1089(1):171-8. PubMed ID: 16635480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel H3 receptor antagonists with improved pharmacokinetic profiles.
    Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Semple G; Ren A; Pereira G; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Lorea J; Grottick AJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4133-6. PubMed ID: 18554904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
    Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics.
    Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Minick DJ; Skone PA; Uings I; McLay IM; Macdonald SJ
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4737-45. PubMed ID: 17616395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.